Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review

被引:86
|
作者
Piska, Kamil [1 ]
Gunia-Krzyzak, Agnieszka [2 ]
Koczurkiewicz, Paulina [1 ]
Wojcik-Pszczola, Katarzyna [1 ]
Pekala, Elzbieta [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Fac Pharm, Dept Pharmaceut Biochem,Med 9, PL-30688 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Fac Pharm, Dept Bioorgan Chem,Chair Organ Chem,Med 9, PL-30688 Krakow, Poland
关键词
Piperlongumine; Piplartine; Natural product compounds; SAR; Ayurveda; Chemotherapy; VIVO GROWTH-INHIBITION; MYELOID-LEUKEMIA CELLS; CANCER-CELLS; IN-VITRO; BIOLOGICAL EVALUATION; ANTITUMOR ACTIVITIES; SIGNALING PATHWAY; APOPTOSIS; PIPER; ROS;
D O I
10.1016/j.ejmech.2018.06.057
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Piperlongumine, also known as piplartine, is an amide alkaloid of Piper longum L (long piper), a medical plant known from Ayurvedic medicine. Although was discovered well over fifty years ago, its pharmacological properties have been uncovered in the past decade. In particular, piperlongumine has been most extensively studied as a potential anticancer agent. Piperlongumine has exhibited cytotoxicity against a broad spectrum of human cancer cell lines, as well as demonstrated antitumor activity in rodents. Piperlongumine has also been found to be a proapoptotic, anti-invasive, antiangiogenic agent and synergize with modern chemotherapeutic agents. Because of its clinical potential, several studies were undertaken to obtain piperlongumine analogues, which have exhibited more potent activity or more appropriate drug-like parameters. In this review, the synthesis of piperlongumine analogues and piperlongumine-based hybrid compounds, as well as their anticancer properties and the molecular basis for their activity are explored. General structure-activity relationship conclusions are drawn and directions for the future research are indicated. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [1] Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents
    Meegan, Mary J.
    Nathwani, Seema
    Twamley, Brendan
    Zisterer, Daniela M.
    O'Boyle, Niamh M.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 453 - 463
  • [2] Cinnamic acid hybrids as anticancer agents: A mini-review
    Feng, Lian-Shun
    Cheng, Jin-Bo
    Su, Wen-Qi
    Li, Hong-Ze
    Xiao, Tao
    Chen, De-An
    Zhang, Zhi-Liu
    [J]. ARCHIV DER PHARMAZIE, 2022, 355 (07)
  • [3] A mini-review on Ru(II)-curcumin metal complexes based anticancer agents
    Mondal, Rajdeep
    Noushija, Mannanthara Kunhumon
    Banu, Sajeetha Parveen
    Pandurangan, Nanjan
    Shanmugaraju, Sankarasekaran
    [J]. INORGANICA CHIMICA ACTA, 2024, 569
  • [4] An Update Mini-Review on the Progress of Azanucleoside Analogues
    Zhang, Yanhua
    Geng, Hao
    Zhang, Junjie
    He, Kehan
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2022, 70 (07) : 469 - 476
  • [5] The Anticancer Potential of Quassinoids-A Mini-Review
    Lu, Cai
    Lu, Si-Nan
    Di, Di
    Tao, Wei-Wei
    Fan, Lu
    Duan, Jin-Ao
    Zhao, Ming
    Che, Chun-Tao
    [J]. ENGINEERING, 2024, 38 : 27 - 38
  • [6] Novel selective anticancer agents based on Sn and Au complexes. Mini-review
    Milaeva, Elena R.
    Shpakovsky, Dmitry B.
    Gracheva, Yulia A.
    Antonenko, Taisiya A.
    Ksenofontova, Tatyana D.
    Nikitin, Evgeny A.
    Berseneva, Daria A.
    [J]. PURE AND APPLIED CHEMISTRY, 2020, 92 (08) : 1201 - 1216
  • [7] Anticancer Potential and Molecular Targets of Pristimerin: A Mini-Review
    Yousef, Bashir A.
    Hassan, Hozeifa M.
    Zhang, Lu-Yong
    Jiang, Zhen-Zhou
    [J]. CURRENT CANCER DRUG TARGETS, 2017, 17 (02) : 100 - 108
  • [8] Isothiocyanates as potential antifungal agents: a mini-review
    Sharma, Rakesh K.
    Patil, Shivani B.
    Jadhav, Ashwini K.
    Karuppayil, Sankunny M.
    [J]. FUTURE MICROBIOLOGY, 2023, : 673 - 679
  • [9] Gold Nanoparticles as Antimicrobial Agents: A Mini-Review
    Sindhu, Ravinder
    Sindhu, Suchita
    Dagar, Mukhan Wati
    Nagoria, Savita
    [J]. INTERNATIONAL JOURNAL OF NANOSCIENCE, 2022, 21 (02)
  • [10] A Comprehensive Description of Hypoxia-inducible Factor 2α Inhibitors as Anticancer Agents: A Mini-review
    Lu, Hongyuan
    Zhu, Yan
    Liu, Wenwu
    Yan, Yuanyuan
    Jiang, Xiaowen
    Wang, Qinbiao
    Zhao, Yanyun
    He, Miao
    Wei, Minjie
    [J]. CURRENT MEDICINAL CHEMISTRY, 2023, 30 (25) : 2835 - 2849